Abstract
Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
| Original language | English |
|---|---|
| Pages (from-to) | 49-50 |
| Number of pages | 2 |
| Journal | Current Drug Safety |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 09-02-2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
- Toxicology
- Pharmacology
Cite this
}
Stereotyped paroxysmal psychiatric symptoms during oculogyric crisis or 'cognitive dystonia' : A case report. / Praharaj, Samir Kumar; Sarkhel, Sujit; Akhtar, Sayeed.
In: Current Drug Safety, Vol. 6, No. 1, 09.02.2011, p. 49-50.Research output: Contribution to journal › Article
TY - JOUR
T1 - Stereotyped paroxysmal psychiatric symptoms during oculogyric crisis or 'cognitive dystonia'
T2 - A case report
AU - Praharaj, Samir Kumar
AU - Sarkhel, Sujit
AU - Akhtar, Sayeed
PY - 2011/2/9
Y1 - 2011/2/9
N2 - Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
AB - Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
UR - http://www.scopus.com/inward/record.url?scp=79551634323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551634323&partnerID=8YFLogxK
U2 - 10.2174/157488611794479982
DO - 10.2174/157488611794479982
M3 - Article
VL - 6
SP - 49
EP - 50
JO - Current Drug Safety
JF - Current Drug Safety
SN - 1574-8863
IS - 1
ER -